Join to View Full Profile
430 E 29th St5th Floor Room 512New York, NY 10016
Dr. Herati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 2011 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
Washington University in St. Louis School of MedicineClass of 2008
Certifications & Licensure
NY State Medical License 2019 - 2026
PA State Medical License 2011 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Flu Vaccine Responses in the Setting of Melanoma Treatment Start of enrollment: 2017 Oct 20
Publications & Presentations
PubMed
- The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response.Aaron L Oom, Kesi K Wilson, Miilani Yonatan, Stephanie Rettig, Heekoung Allison Youn
Journal of Virology. 2025-03-31 - Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1CD8T cells.Zhen Zhang, Marlene Langenbach, Sagar Sagar, Viktor Fetsch, Jonas Stritzker
Nature Immunology. 2025-01-01 - 3 citationsSARS-CoV-2 inflammation durably imprints memory CD4 T cells.Sophie L Gray-Gaillard, Sabrina M Solis, Han M Chen, Clarice Monteiro, Grace Ciabattoni
Science Immunology. 2024-06-21
Journal Articles
- Research Paper Deep Immune Profiling by Mass Cytometry Links Human T and NK Cell Differentiation and Cytotoxic Molecule Expression PatternsRamin Herati, MD, ScienceDirect
- Research Paper Deep Immune Profiling by Mass Cytometry Links Human T and NK Cell Differentiation and Cytotoxic Molecule Expression PatternsRamin Sedaghat Herati, Kyong-Mi Chang, ScienceDirect
Press Mentions
- Patients Recovered from COVID-19 May Require Just One Dose of mRNA VaccineMarch 9th, 2021
- Patients Recovered from COVID-19 May Require Just One Dose of mRNA VaccineMarch 9th, 2021
Penn Team Tracks Rare T Cells in Blood to Better Understand Annual Flu VaccineFebruary 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
